Literature DB >> 29080344

Bile Acids and Cancer: Direct and Environmental-Dependent Effects.

Agostino Di Ciaula1, David Q-H Wang2, Emilio Molina-Molina3, Raquel Lunardi Baccetto3, Giuseppe Calamita4, Vincenzo O Palmieri4, Piero Portincasa3.   

Abstract

Bile acids (BAs) regulate the absorption of fat-soluble vitamins, cholesterol and lipids but have also a key role as singalling molecules and in the modulation of epithelial cell proliferation, gene expression and metabolism. These homeostatic pathways, when disrupted, are able to promote local inflammation, systemic metabolic disorders and, ultimately, cancer. The effect of hydrophobic BAs, in particular, can be linked with cancer in several digestive (mainly oesophagus, stomach, liver, pancreas, biliary tract, colon) and extra-digestive organs (i.e. prostate, breast) through a complex series of mechanisms including direct oxidative stress with DNA damage, apoptosis, epigenetic factors regulating gene expression, reduced/increased expression of nuclear receptors (mainly farnesoid X receptor, FXR) and altered composition of gut microbiota, also acting as a common interface between environmental factors (including diet, lifestyle, exposure to toxics) and the molecular events promoting cancerogenesis. Primary prevention strategies (i.e. changes in dietary habits and lifestyle, reduced exposure to environmental toxics) mainly able to modulate gut microbiota and the epigenome, and the therapeutic use of hydrophilic BAs to counterbalance the negative effects of the more hydrophobic BAs might be, in the near future, part of useful tools for cancer prevention and management.

Entities:  

Keywords:  Bile acids. Cancer. Microbiota. FXR. Environment. Epigenome.

Mesh:

Substances:

Year:  2017        PMID: 29080344     DOI: 10.5604/01.3001.0010.5501

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  26 in total

1.  Pleiotropic roles of FXR in liver and colorectal cancers.

Authors:  Xiongfei Huang; Mingjie Fan; Wendong Huang
Journal:  Mol Cell Endocrinol       Date:  2022-01-04       Impact factor: 4.102

2.  Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021.

Authors:  Wen-Xing Ding; Hua Wang; Yuxia Zhang
Journal:  Liver Res       Date:  2022-01-29

Review 3.  Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer?

Authors:  Sebastian F Schoppmann; Ivan Kristo; Martin Riegler
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-05

Review 4.  Current and future roles of mucins in cholangiocarcinoma-recent evidences for a possible interplay with bile acids.

Authors:  Elisa Danese; Andrea Ruzzenente; Martina Montagnana; Patricia Marie-Jeanne Lievens
Journal:  Ann Transl Med       Date:  2018-09

Review 5.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31

Review 6.  Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.

Authors:  Edit Mikó; Tünde Kovács; Éva Sebő; Judit Tóth; Tamás Csonka; Gyula Ujlaki; Adrienn Sipos; Judit Szabó; Gábor Méhes; Péter Bai
Journal:  Cells       Date:  2019-03-29       Impact factor: 6.600

7.  Critical Care Aspects of Gallstone Disease.

Authors:  Piero Portincasa; Emilio Molina-Molina; Gabriella Garruti; David Q-H Wang
Journal:  J Crit Care Med (Targu Mures)       Date:  2019-02-04

8.  Acute and subacute toxicity tests of goat bile in BALB/c mice.

Authors:  Heny Arwati; Windya T Hapsari; Kartika A Wardhani; Kholida N Aini; Ramadhani R Bahalwan; Puspa Wardhani; Willy Sandhika
Journal:  Vet World       Date:  2020-03-20

9.  Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer.

Authors:  Qian Zhang; Rui Huang; Hanqing Hu; Lei Yu; Qingchao Tang; Yangbao Tao; Zheng Liu; Jiaying Li; Guiyu Wang
Journal:  iScience       Date:  2020-08-14

Review 10.  Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?

Authors:  Jesús Cosín-Roger; Dolores Ortiz-Masia; Maria Dolores Barrachina; Sara Calatayud
Journal:  Cells       Date:  2020-10-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.